EPIRUS Biopharmaceuticals To Present At Wedbush Life Sciences Management Access Conference

EPIRUS Biopharmaceuticals, Inc. (EPIRUS, NASDAQ:EPRS), a Boston-based biopharmaceutical company focused on the global development and commercialization of biosimilar monoclonal antibodies, today announced that the company will present at the Wedbush Life Sciences Management Access Conference at 4:15 p.m. EDT, Tuesday, Aug. 12, at the Le Parker Meridien in New York City. The presentation will include discussion of the company’s recent developments, business model and pipeline.

Help employers find you! Check out all the jobs and post your resume.